Kamimatsuse Arata, Matsuura Kaoru, Moriya Shogo, Fukuba Ikuko, Yamaoka Hiroaki, Fukuda Emi, Kamei Naomi, Hiyama Keiko, Sueda Taijiro, Hiyama Eiso
Department of Surgery, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan.
Pediatr Blood Cancer. 2009 Jul;52(7):777-83. doi: 10.1002/pbc.21977.
The caspase-8 gene (CASP8) is frequently inactivated in unfavorable neuroblastomas through DNA methylation. The present study utilized oligoarrays to evaluate the methylation status of a CpG island located between exons 2 and 3 of caspase 8 in neuroblastomas.
DNA derived from 70 neuroblastomas was amplified by PCR after bisulfate modification and subjected to analysis on a self-made oligoarray that utilized a polycarbodiimide-coated slide to detect methylation of six intragenic CpG islands of caspase 8. In 30 cases, the methylation status was also analyzed by sequencing. In six cases, the PCR product was cloned into a vector and analyzed.
Among the 70 tumor-derived DNAs, methylation was not detected in 18 cases, one methylated CpG was found in 12 cases, two in 18 cases, three in 3 cases, four in 8 cases, five in 1 case and six in 10 cases. All methylated CpG loci detected by sequencing were detected by oligoarray, but some methylated CpGs in three loci were detected by oligoarray alone. In these discrepant loci, methylation was detected in some clones after subcloning, indicating that the oligoarray might be more sensitive than sequencing. The CASP8 expression level was depressed in the tumors having two distinct CpG doublets. These results were significantly correlated with MYCN amplification and with clinical outcomes.
A significant difference in the methylation status within the CpG island of CASP8 was shown between favorable and unfavorable subtypes, and CASP8 methylation detected by oligoarray may be useful in the clinical evaluation of neuroblastomas.
胱天蛋白酶8基因(CASP8)在预后不良的神经母细胞瘤中常因DNA甲基化而失活。本研究利用寡核苷酸芯片评估神经母细胞瘤中位于胱天蛋白酶8第2外显子和第3外显子之间的一个CpG岛的甲基化状态。
对70例神经母细胞瘤来源的DNA进行亚硫酸氢盐修饰后通过PCR扩增,然后在自制的寡核苷酸芯片上进行分析,该芯片使用聚碳二亚胺包被的载玻片来检测胱天蛋白酶8的6个基因内CpG岛的甲基化情况。在30例病例中,还通过测序分析甲基化状态。在6例病例中,将PCR产物克隆到载体中并进行分析。
在70份肿瘤来源的DNA中,18例未检测到甲基化,12例发现1个甲基化的CpG,18例发现2个,3例发现3个,8例发现4个,1例发现5个,10例发现6个。测序检测到的所有甲基化CpG位点均被寡核苷酸芯片检测到,但有3个位点中的一些甲基化CpG仅被寡核苷酸芯片检测到。在这些不一致的位点,亚克隆后在一些克隆中检测到甲基化,表明寡核苷酸芯片可能比测序更敏感。在具有两个不同CpG双峰的肿瘤中,CASP8表达水平降低。这些结果与MYCN扩增及临床结局显著相关。
在预后良好和预后不良的亚型之间,CASP8的CpG岛内甲基化状态存在显著差异,寡核苷酸芯片检测到的CASP8甲基化可能有助于神经母细胞瘤的临床评估。